Calithera Biosciences Inc

NASDAQ:CALA  
0.72
-0.08 (-10.39%)
Earnings Announcements

Calithera Biosciences Reports Third Quarter 2021 Financial Results And Recent Highlights

Published: 11/09/2021 22:25 GMT
Calithera Biosciences Inc (CALA) - Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights.
Q3 Revenue $6.8 Million.
Qtrly Loss per Share $0.15.
Q3 Earnings per Share View $-0.23, Revenue View $0.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.